1. Patterns of First Recurrence and Oncological Outcomes in Locally Advanced Cervical Cancer Patients: Does Surgical Staging Play a Role?
- Author
-
Bebia, Vicente, Díaz-Feijoo, Berta, Tejerizo, Álvaro, Torne, Aureli, Benito, Virginia, Hernández, Alicia, Gorostidi, Mikel, Domingo, Santiago, Bradbury, Melissa, Luna-Guibourg, Rocío, and Gil-Moreno, Antonio
- Subjects
CERVIX uteri tumors ,LYMPHADENECTOMY ,T-test (Statistics) ,SCIENTIFIC observation ,FISHER exact test ,MINIMALLY invasive procedures ,TREATMENT effectiveness ,RETROSPECTIVE studies ,DESCRIPTIVE statistics ,MANN Whitney U Test ,CHI-squared test ,LONGITUDINAL method ,KAPLAN-Meier estimator ,LOG-rank test ,RESEARCH ,TUMOR classification ,DATA analysis software ,CONFIDENCE intervals - Abstract
Simple Summary: Whenever cancer of the uterine cervix is diagnosed in a locally advanced stage, it is important to know whether it affects the lymph nodes above the pelvis or not. There are two ways of ruling it out: by a surgery, called paraaortic lymphadenectomy, or by imaging tests. With this study, we wanted to see whether paraaortic lymphadenectomy affected the natural evolution of the tumor by looking at the differences in the recurrence rate between both groups. We used a statistical technique that makes both groups comparable. We observed that patients who underwent a paraaortic surgery suffered more recurrences (both at the lymph nodes and at distance) and survived less than those treated only with the information from the imaging tests. Background: We aimed to determine whether surgical aortic staging by minimally invasive paraaortic lymphadenectomy (PALND) affects the pattern of first recurrence and survival in treated locally advanced cervical cancer (LACC) patients when compared to patients staged by imaging (noPALND). Methods: This study was a multicenter observational retrospective cohort study of patients with LACC treated at tertiary care hospitals throughout Spain. The inclusion criteria were histological diagnosis of squamous carcinoma, adenosquamous carcinoma, and/or adenocarcinoma; FIGO stages IB2, IIA2-IVA (FIGO 2009); and planned treatment with primary chemoradiotherapy between 2000 and 2016. Propensity score matching (PSM) was performed before the analysis. Results: After PSM and sample replacement, 1092 patients were included for analysis (noPALND n = 546, PALND n = 546). Twenty-one percent of patients recurred during follow-up, with the PALND group having almost double the recurrences of the noPALND group (noPALND: 15.0%, PALND: 28.0%, p < 0.001). Nodal (regional) recurrences were more frequently observed in PALND patients (noPALND:2.4%, PALND: 11.2%, p < 0.001). Among those who recurred regionally, 57.1% recurred at the pelvic nodes, 37.1% recurred at the aortic nodes, and 5.7% recurred simultaneously at both the pelvic and aortic nodes. Patients who underwent a staging PALND were more frequently diagnosed with a distant recurrence (noPALND: 7.0%, PALND: 15.6%, p < 0.001). PALND patients presented poorer overall, cancer-specific, and disease-free survival when compared to patients in the noPALND group. Conclusion: After treatment, surgically staged patients with LACC recurred more frequently and showed worse survival rates. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF